Image

Efficacy Trial Healthy Dads, Healthy Kids for Hispanic Fathers and Children

Efficacy Trial Healthy Dads, Healthy Kids for Hispanic Fathers and Children

Non Recruiting
5-65 years
All
Phase N/A

Powered by AI

Overview

Hispanic men and children experience health disparities for overweight and obesity-related medical conditions, and therefore family level obesity prevention programs for Hispanic populations are needed. 'Healthy Dads Healthy Kids' is the first program to primarily target fathers for obesity prevention for themselves and their children, with significant and clinically relevant treatment effects. This is an efficacy trial to assess a culturally adapted 'Healthy Dads Healthy Kids' for Hispanic families.

Description

Hispanics in the United States face health disparities for obesity and related medical conditions, such as cardiovascular disease and diabetes. Targeting families to promote healthy lifestyle behaviors has been identified as an effective strategy to prevent obesity. With the importance of familism (family cohesion) among the Hispanic population, a family based intervention is especially desirable as an engaging strategy to promote behaviors that support a healthy weight status and decrease obesity related health disparities for Hispanics. Emerging evidence supports the need to include and target fathers in family based lifestyle behavior interventions. Healthy Dads Healthy Kids (HDHK) is an evidence based program developed in Australia, shown to have significant weight and behavior treatment effects for fathers and their children, compared to controls. The HDHK program is based on Social Cognitive Theory and Family Systems Theory and aims to promote increased physical activity and improved dietary intake for fathers and their children. An important innovation in the program is that fathers and children attend together and are both targeted as agents of behavior change for each other (reciprocal reinforcement) and to participate in fun, family activities together. HDHK was culturally adapted for Hispanic families following the Ecological Validity Model by this research team, with input from a community Hispanic family panel, expert committee and the developer of the HDHK program. The resulting Papás Saludables, Niños Saludables (PSNS) program is a 10-week group-based intervention that meets weekly.

This randomized controlled trial of PSNS is powered to detect a clinically meaningful change in father's weight and children's moderate to vigorous physical activity. The study will also assess other behavioral (dietary intake, sedentary time, screen media use, and parenting practices), psychosocial (familism, acculturation, and co-parenting alliance) and biological (child BMI z-score, father's non-HDL, HgbA1C, and BP) outcomes. Hispanic men with overweight or obesity who are a father figure (biological father, step father, grandfather, adult older brother, etc) to a 5-11 child will be enrolled in the study in waves. Participants are enrolled as a family unit and includes the father, child(ren) (up to 3 siblings) and mother/partner (if available). After screening and baseline data is complete for a wave, the family is randomized to receive a standard of care control or the group-based culturally adapted PSNS. Follow-up assessments will be done at 4 months and 12 months.

The study includes a partnership with the YMCA of Greater Houston to provide a venue for where to deliver the program.

Eligibility

FATHER

  • Father or significant male role model (e.g. step father, grandfather, uncle, or older brother) of a child 5-11 years old
  • Age 18-65 year old
  • Living in Greater Houston Area
  • Self-identify as Hispanic or Latino
  • Able to read and write in Spanish or English
  • BMI >/=25 - 40
  • Pass the 2015 American College of Sports Medicine's exercise participation health screener
        CHILD • 5-11 year old child and up to three siblings, whose father/significant male role
        model is participating
        MOTHER (If available) 1) Significant female role model such as biological mother, step
        mother, foster mother, grandmother, aunt or older sister; or other co-parent/partner to
        participating children
        Exclusion Criteria:
        FATHER
          -  Known diagnosis of diabetes without medical clearance from health care provider;
          -  Known diagnosis of cardio-vascular disease (cardiac arrhythmia, h/o myocardial
             infarction, heart valve disease, heat failure, heart transplantation, congenital heart
             disease, h/o heat surgery, coronary angioplasty, or stroke)
          -  Currently, or in the past 6 months, in a weight management program
          -  Currently, or in the past 6 months, taking medicine that can affect weight or might be
             affected by weight loss
          -  Any other disease or condition affecting their ability to participate in physical
             activities/exercise (e.g., physical disability, severe asthma)
          -  Any other disease or condition affecting their ability to participate in group
             classroom activities including cognitive impairment (e.g., Down's syndrome, Fragile
             X), or psychiatric functioning (e.g. schizophrenia)
          -  Plans of moving away from Harris County in the next year
          -  Not passing the 2015 American College of Sports Medicine's exercise participation
             health screener AND NOT provide a medical clearance from a licensed medical provider
             (MD, NNP, PA)
          -  Unwilling to wear accelerometer for a 7 day study period at the three assessment
             points.
          -  BMI less than 25 or greater than 40.
          -  HbgA1C equal or greater than 6.5% at baseline data collection without medical
             clearance from health care provider.
          -  Has previously participated in studies on the Healthy Dads Healthy Kids' for US
             Hispanics
          -  History of myocarditis from COVID infection or vaccine
        CHILD
          -  Not within the 5-11 year old child age range
          -  Known diagnosis of diabetes
          -  Known diagnosis of cardio-vascular disease (cardiac arrhythmia, h/o myocardial
             infarction, heart valve disease, heat failure, heart transplantation, congenital heart
             disease, h/o heat surgery or coronary angioplasty)
          -  Inability to participate in regular physical education classes in school due to health
             or physical condition (e.g. physical disability, severe asthma)
          -  Any disease or condition affecting their ability to participate in group classroom
             activities including cognitive impairment (e.g. Down's syndrome, Fragile X), or
             developmental problems (e.g. autism)
        MOTHER
        • No father figure to her children enrolled in the study

Study details
    Obesity
    Obesity
    Childhood
    Physical Activity
    Dietary Intake

NCT05334420

Baylor College of Medicine

20 August 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.